Find undervalued US stocks
in 30 minutes.
Type a US ticker. Our agents read every public filing and run the numbers the way Buffett and Klarman do — then hand you a clear verdict: Buy, Watch, Pass, or Avoid.
No advice. No predictions. Just the work.
Three steps. About thirty minutes.
A thesis you'd actually trust to make the call.
No black boxes. Each step produces an artifact you can inspect — the raw filings, the analyst memo, the audit log of every claim.
Everything the company has said.
The agents do what most investors don't have time to do: read everything.
The frameworks great investors actually use.
Specialist agents look at the business the way Buffett, Klarman, Hohn, and Chanos would.
Every claim, audited against the source.
An independent fact-checker grades every numeric claim and quotation against the filings.
Here's what the agents wrote about SPCX.
Generated end-to-end from public filings on June 6, 2026. Every number below is straight from the analysis — intrinsic value, the margin of safety, and the kill criteria the agents named.
The agents' bottom line
Verdict: PendingPrice · Moderate conviction · Quality 5/10. At $0.00 against a base-case intrinsic value of $1,250, the margin of safety is —.
The full thesis triangulates intrinsic value three ways, weighs four investor lenses, and names the conditions that would break the case — all checked against the filings.
Most people who'd love to invest like Buffett
don't have his hours to read.
"Read 500 pages like this every day. That's how knowledge works. It builds up, like compound interest."
Warren Buffett — on what young investors should do, asked at Columbia Business School
Buffett reads roughly 500 pages a day. Klarman does the same. Hohn, Pabrai, Greenblatt — every great value investor we've read about treats reading as the job. Not a chore that gets in the way of investing. The reading is the investing. The decisions are a byproduct.
It's a craft built over decades. They have specific frameworks — owner earnings, intrinsic value, margin of safety, circle of competence — that took years to refine and a lifetime to apply consistently. The principles are public; the discipline is private.
Most of us who'd love to think this way don't get the chance. A working investor has maybe an hour, on a good week, to look at a stock they're curious about. A 200-page 10-K, an earnings call transcript, three years of proxy filings, the competitor's K, the macro picture — that's a week of focused reading. The gap isn't intelligence. The gap is hours.
Six specialists.
One coherent thesis.
Each agent owns a single question. None of them try to be a generalist. The output is a thesis where every claim has a name attached to it — and a citation underneath.
Moat
Does this business have a real, lasting advantage? Reads the company's filings (and its competitors') looking for the kind of moat Buffett invests in — pricing power, hard-to-switch products, network effects — and the rarer one that's getting wider.
Financials
How healthy are the actual numbers? Reads ten years of the company's financial statements — sales, profit margins, the real cash it earns — and flags anything that looks fishy or has been quietly getting worse.
Intrinsic value
What is the stock actually worth? Estimates fair value three different ways and shows you where the methods agree, where they disagree, and how the answer changes under different assumptions.
Management quality
Are the people running it any good — and honest? Reads ten years of shareholder letters and executive-pay plans, and judges whether leadership has earned trust with how they spend the cash and reward themselves.
Capital allocation
Where did the company's cash actually go? Back into the business? Acquisitions, share buybacks, dividends, paying down debt? More importantly — did each dollar earn a good return?
Bear case & kill criteria
What would make this a bad bet? Looks for accounting warning signs, regulatory threats, and long-term headwinds — then names four specific things that, if they happen, mean it's time to sell. Your watchlist alerts you if any trigger.
Two plans. Same product.
Pick by how much you research.
Every feature is in every plan. The only difference is how many fresh theses you can run each month. Try one for free before you pick.
One free thesis on any US ticker. No card. We'll email it in thirty minutes.
If it doesn't change how you think about that company, you'll never hear from us again.
The questions thoughtful investors ask first.
Is this investment advice?
No. Nothing on this site or in any thesis we deliver constitutes investment, financial, or legal advice. We produce research, in the same sense that a sell-side analyst report or a Morningstar note is research. You make every decision yourself.
Which tickers are covered?
Every US-listed company that files with the SEC — roughly 5,800 names across NYSE and Nasdaq. International coverage is on the roadmap; we'd rather do US thoroughly than the world shallowly.
What data sources do you use?
SEC EDGAR for filings (10-K, 10-Q, 8-K, DEF 14A), the company's own investor relations site for earnings releases and transcripts, and a single live-price feed. No paid data resellers. Every figure in a thesis is traceable back to a primary source.
How long does a thesis take to generate?
About thirty minutes from ticker entry to email delivery on the standard queue. Analyst tier targets fifteen. Complex names with thirty years of filings can stretch to forty-five.
Can I trust the numbers?
Every numeric claim and every quotation is independently audited against the source filing before delivery. The result is reported as a trust scoreboard with every thesis — matched, approximate, or unverifiable, with the page reference. You can falsify any line in under a minute.
What happens if a thesis becomes wrong?
Every thesis ships with four named kill criteria — conditions that, if triggered, falsify the thesis. We watch the filings and alert you when one triggers. The product is built to fail loudly, not quietly.
Try it on any US ticker.
The first thesis is on us.
Type a ticker, give us your email, and we'll email a 12,000-word thesis in thirty minutes. No card. No upsell. If it doesn't change how you think about that company, you'll never hear from us again.
By submitting, you agree to our terms. We'll never sell your address.